Transplantation

Journal

Publication Venue For

  • Life-supporting Kidney Xenotransplantation From Genetically Engineered Pigs in Baboons: A Comparison of Two Immunosuppressive Regimens.  103:2090-2104. 2019
  • Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.  103:1591-1602. 2019
  • HLA Class I-sensitized Renal Transplant Patients Have Antibody Binding to SLA Class I Epitopes.  103:1620-1629. 2019
  • A Video Intervention to Increase Organ Donor Registration at the Department of Motorized Vehicles. 2019
  • Center Variation and Risk Factors for Failure to Complete 6 Month Postdonation Follow-up Among Obese Living Kidney Donors.  103:1450-1456. 2019
  • Ethnic and Age Disparities in Outcomes Among Liver Transplant Waitlist Candidates.  103:1425-1432. 2019
  • Establishing a Core Outcome Measure for Life Participation: A Standardized Outcomes in Nephrology-kidney Transplantation Consensus Workshop Report.  103:1199-1205. 2019
  • Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies.  103:1131-1139. 2019
  • Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living Donor Kidney Transplantation. 2019
  • Perspectives on the Optimal Genetically Engineered Pig in 2018 for Initial Clinical Trials of Kidney or Heart Xenotransplantation.  102:1974-1982. 2018
  • Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation.  102:2080-2087. 2018
  • Heavy Alcohol Use among Deceased Donors Does Not Impact Recipient Outcomes after Liver Transplantation.  102:1864-1869. 2018
  • Establishing a Core Outcome Measure for Graft Health: A Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) Consensus Workshop Report.  102:1358-1366. 2018
  • Overcoming Coagulation Dysregulation in Pig Solid Organ Transplantation in Nonhuman Primates: Recent Progress.  102:1050-1058. 2018
  • Immune Responses of HLA Highly Sensitized and Nonsensitized Patients to Genetically Engineered Pig Cells.  102:e195-e204. 2018
  • Intraoperative Management of Liver Transplant Patients Without the Routine Use of Renal Replacement Therapy.  102:e229-e235. 2018
  • Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.  102:471-477. 2018
  • Patient and Kidney Allograft Survival in Recipients with End-Stage Renal Disease from Amyloidosis.  102:300-309. 2018
  • Swine Leukocyte Antigen Class II Is a Xenoantigen.  102:249-254. 2018
  • Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up.  102:135-139. 2018
  • An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.  101:2330-2339. 2017
  • Regulation of Clinical Xenotransplantation-Time for a Reappraisal.  101:1766-1769. 2017
  • Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.  101:1527-1534. 2017
  • Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation.  101:1551-1568. 2017
  • Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells from GGTA1/CMAH/B4GalNT2, and SLA Class i Knockout Pigs.  101:e86-e92. 2017
  • Cost-effectiveness of antibody-based induction therapy in deceased donor kidney transplantation in the United States.  101:1234-1241. 2017
  • Effect of a mobile web app on kidney transplant candidates' knowledge about increased risk donor kidneys: A randomized controlled trial.  101:1167-1176. 2017
  • Eliminating xenoantigen expression on swine rbc.  101:517-523. 2017
  • Progress in Clinical Encapsulated Islet Xenotransplantation.  100:2301-2308. 2016
  • De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury.  100:2194-2202. 2016
  • Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic.  100:2039-2047. 2016
  • Executive summary of IPITA-TTS opinion leaders report on the future of b-cell replacement.  100:e25-e31. 2016
  • Long-Term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation.  100:1294-1298. 2016
  • APOL1 genotype and kidney transplantation outcomes from deceased african American donors.  100:194-202. 2016
  • Eomesoderminlo CTLA4hi Alloreactive CD8+ Memory T Cells Are Associated with Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.  100:91-102. 2016
  • Immunogenicity of renal microvascular endothelial cells from genetically modified pigs.  100:533-537. 2016
  • Long-Term outcomes after liver transplantation among human immunodeficiency virus-infected recipients.  100:141-146. 2016
  • Report from IPITA-TTS opinion leaders meeting on the future of β-cell replacement.  100:S1-S44. 2016
  • The kidney-vascular-bone axis in the chronic kidney disease-mineral bone disorder.  100:497-505. 2016
  • David K. C. Cooper, MD, PhD: Professor of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, PA.  99:1310-1311. 2015
  • Choosing the order of deceased donor and living donor kidney transplantation in pediatric recipients: A Markov decision process model.  99:360-366. 2015
  • Center-level variation in the development of delayed graft function after deceased donor kidney transplantation.  99:997-1002. 2015
  • Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients.  99:805-810. 2015
  • Islet size index as a predictor of outcomes in clinical islet autotransplantation.  97:1286-1291. 2014
  • The authors' reply.  97. 2014
  • Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria.  97:1043-1048. 2014
  • Increased soluble CD154 (CD40 Ligand) levels in xenograft recipients correlate with the development of de novo anti-pig IgG antibodies.  97:502-508. 2014
  • Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.  97:446-450. 2014
  • Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.  98:857-863. 2014
  • Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: A retrospective analysis.  98:1019. 2014
  • Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: A retrospective analysis.  98:1119-1127. 2014
  • New concepts of immune modulation in xenotransplantation.  96:937-945. 2013
  • Order of donor type in pediatric kidney transplant recipients requiring retransplantation.  96:487-493. 2013
  • Hepatitis C virus infection in heart transplantation: Is ventricular assist device therapy an option?.  96. 2013
  • Is there a correlation between anti-pig antibody levels in humans and geographic location during childhood?.  96:387-393. 2013
  • Outcomes in systemic sclerosis-related lung disease after lung transplantation.  95:975-980. 2013
  • Erratum: Is decedent race an independent predictor of organ donor consent or merely a surrogate marker of socioeconomic status (Transplantation (2012) 2:94 (873)).  95. 2013
  • Ganciclovir prophylaxis improves late murine cytomegalovirus-induced renal allograft damage.  95:48-53. 2013
  • A syndrome of severe hypoglycemia and acidosis in young immunosuppressed diabetic monkeys and pigs-association with sepsis.  94:1187-1191. 2012
  • Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients.  94:971-977. 2012
  • Is decedent race an independent predictor of organ donor consent or merely a surrogate marker of socioeconomic status?.  94:873-878. 2012
  • Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients.  93:1075-1085. 2012
  • Reply to "genetic determinants of mycophenolate-related anemia and leukopenia after transplantation".  93. 2012
  • Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation.  93:794-798. 2012
  • T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons.  93:769-776. 2012
  • Human CD55 expression blocks hyperacute rejection and restricts complement activation in gal knockout cardiac xenografts.  93:686-692. 2012
  • Associations of ABCB1 3435C>T and IL-10 -1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.  92:1342-1347. 2011
  • Total lymphoid irradiation in heart transplantation: Long-term efficacy and survival-an 18-year experience.  92:1159-1164. 2011
  • African American living-kidney donors should be screened for apol1 risk alleles.  92:722-725. 2011
  • Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation.  92:759-766. 2011
  • Primary porcine kupffer cell phagocytosis of human platelets involves the CD18 receptor.  92:739-744. 2011
  • Comparison of gal and non-gal-mediated cardiac xenograft rejection.  91:968-975. 2011
  • Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.  91:309-316. 2011
  • Identification of new carbohydrate and membrane protein antigens in cardiac Xenotransplantation.  91:287-292. 2011
  • Novel polymorphisms associated with tacrolimus trough concentrations: Results from a multicenter kidney transplant consortium.  91:300-308. 2011
  • Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation.  91:191-198. 2011
  • Chemokines and their receptors in human renal allotransplantation.  91:70-77. 2011
  • Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: Results from a multicenter study.  90:1099-1105. 2010
  • The spleen as a site for hematopoiesis.  90:1040-1041. 2010
  • Non-human primate regulatory T cells: Current biology and implications for transplantation.  90:811-816. 2010
  • Hepatic function after genetically engineered pig liver transplantation in baboons.  90:483-493. 2010
  • Evidence for antibody-mediated injury as a Major determinant of late kidney allograft failure.  90:68-74. 2010
  • Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: An analysis of the United network for organ sharing database.  88:842-846. 2009
  • Pig liver xenotransplantation as a bridge to allotransplantation: Which patients might benefit?.  88:1041-1049. 2009
  • Combined heart and liver transplantation: A single-center experience.  88:219-225. 2009
  • ABO incompatible renal transplantation: A paradigm ready for broad implementation.  87:1246-1255. 2009
  • Adenovirus infection activates akt1 and induces cell proliferation in pancreatic islets1.  87:821-824. 2009
  • The innate immune response and activation of coagulation in ±1,3-galactosyltransferase gene-knockout xenograft recipients.  87:805-812. 2009
  • Hormonal therapy to the brain-dead potential organ donor: The misnomer of the "papworth cocktail".  86:1479. 2008
  • Sirolimus As Primary Immunosuppressant Reduces Left Ventricular Mass and Improves Diastolic Function of the Cardiac Allograft.  86:1395-1400. 2008
  • Suppressive efficacy and proliferative capacity of human regulatory t cells in allogeneic and xenogeneic responses.  86:1452-1462. 2008
  • Atorvastatin down-regulates the primate cellular response to porcine aortic endothelial cells in vitro.  86:733-737. 2008
  • Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells.  86:702-709. 2008
  • Erratum: Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin (Transplantation (1999) 68:11 (1660-1673)).  86:482. 2008
  • Erratum: Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients (Transplantation (1999) 68:2 (215-219)).  86:482. 2008
  • Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: Ineffective usage of renal allografts.  85:935-942. 2008
  • Retraction: Peritransplant tolerance induction with anti-CD3-immunotoxin: A matter of proinflammatory cytokine control (Transplantation (1998) 65, 9, (1159-1169)).  85:920. 2008
  • ABO-incompatible transplantation: Less may be more.  84. 2007
  • The impact of left ventricular systolic dysfunction on survival after renal transplantation.  84:1610-1617. 2007
  • Response to commentaries on "α1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: Where do we go from here?".  84:1212-1213. 2007
  • α1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: Where do we go from here?.  84:1-7. 2007
  • Gene expression of porcine lymphotrophic herpesvirus-1 in miniature swine with posttransplant lymphoproliferative disorder.  83:87-90. 2007
  • Is xenotransplantation of embryonic stem cells a realistic option?.  83:333-335. 2007
  • Reduction of early graft loss after intraportal porcine islet transplantation in monkeys.  83:202-210. 2007
  • Sodium iodide symporter (hNIS) permits molecular imaging of gene transduction in cardiac transplantation.  84:1662-1666. 2007
  • Factors affecting graft survival after liver transplantation from donation after cardiac death donors.  82:1683-1688. 2006
  • Hormonal therapy of the brain-dead organ donor: Experimental and clinical studies.  82:1396-1401. 2006
  • Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival.  82:1787-1791. 2006
  • Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay.  82:663-668. 2006
  • Allosensitization does not increase the risk of xenoreactivity to α1,3-galactosyltransferase gene-knockout miniature swine in patients on transplantation waiting lists.  82:314-319. 2006
  • Erratum (Retracted): Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: Absence of chronic allograft nephropathy (Transplantation (June 27, 2000) 69, 12, (2497-2503)).  82:577. 2006
  • Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome.  82:501-507. 2006
  • Elicited antibodies in baboons exposed to tissues from α1,3-galactosyltransferase gene-knockout pigs.  81:1058-1062. 2006
  • Immunological unresponsiveness in chimeric miniature swine following MHC-mismatched spleen transplantation.  80:1791-1804. 2005
  • alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months..  80:1493-1500. 2005
  • Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.  80:1174-1180. 2005
  • α1,3-galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months.  80:1493-1500. 2005
  • Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.  80:1051-1059. 2005
  • Mycophenolate mofetil: Ten years of clinical experience. Introduction.  80. 2005
  • Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium?.  80:660-665. 2005
  • Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: An alternative for type 1 primary hyperoxaluria.  80:421-424. 2005
  • United Network for Organ Sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data [4].  79:623. 2005
  • Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways.  79:409-418. 2005
  • Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: Are they two different diseases?.  79:244-247. 2005
  • Porcine hematopoietic progenitor cell transplantation in nonhuman primates: A review of progress.  79:1-9. 2005
  • Cardiac xenotransplantation: Progress toward the clinic.  78:1569-1575. 2004
  • Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: A report from the Israel penn international transplant tumor registry.  78:1676-1682. 2004
  • T cells from presensitized donors fail to cause graft-versus-host disease in a pig-to-mouse xenotransplantation model.  78:1609-1617. 2004
  • Reduction of consumptive coagulopathy using porcine cytomegalovirus-free cardiac porcine grafts in pig-to-primate xenotransplantation.  78:1449-1453. 2004
  • Two-dose daclizumab induction therapy in 209 liver transplants: A single-center analysis.  78:1212-1217. 2004
  • Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma.  78:972-977. 2004
  • α1-3-galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-gal antobodies.  78:15-20. 2004
  • Acute vascular rejection of xenografts: Roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity.  77:1735-1741. 2004
  • Leflunomide therapy for cytomegalovirus disease in renal allograft recepients.  77:1460-1461. 2004
  • Polyomavirus nephropathy: What have we learned?.  77:1313-1318. 2004
  • Right donor nephrectomy: A comparison of hand-assisted transperitoneal and retroperitoneal laparoscopic approaches.  77:521-525. 2004
  • West Nile virus encephalitis in organ transplant recipients: Another high-risk group for meningoencephalitis and death?.  77:466-469. 2004
  • Alloantibody and xenoantibody cross-reactivity in transplantation.  77:1-5. 2004
  • Posttransplant lymphoproliferative disease after allogeneic transplantation of the spleen in miniature swine..  78:286-291. 2004
  • The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.  76:1583-1588. 2003
  • Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis.  76:650-656. 2003
  • Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.  76:489-495. 2003
  • Donors with central nervous system malignancies: Are they truly safe?.  76:340-343. 2003
  • Allogeneic bone marrow inhibits T-cell activation and clonal expansion in vitro.  76:237-243. 2003
  • Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isoiated human pancreatic islets.  76:252-261. 2003
  • Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H).  76:120-129. 2003
  • Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation.  75:1841-1847. 2003
  • Spleen transplantation in miniature swine: Surgical technique and results in major histocompatibility complex-matched donor and recipient pairs.  75:1799-1806. 2003
  • Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness.  75:1615-1624. 2003
  • Pig cells that lack the gene for α1-3 galactosyltransferase express low levels of the gal antigen.  75:430-436. 2003
  • Xenogeneic thymus transplantation in a pig-to-baboon model.  75:282-291. 2003
  • MALToma: A Helicobacter pylori-associated malignancy in transplant patients: A report from the Israel Penn International Transplant Tumor Registry with a review of published literature.  75:225-228. 2003
  • Bone mineral density changes within six months of renal transplantation.  75:49-54. 2003
  • Bone mineral density changes within six months of renal transplantation..  75:49-54. 2003
  • Liver transplant-associated graft-versus-host disease.  75:118-126. 2003
  • Maximizing renal artery length in right laparoscopic donor nephrectomy by retrocaval exposure of the aortorenal junction.  75:83-85. 2003
  • BK virus and SV40 co-infection in polyomavirus nephropathy.  74:1497-1504. 2002
  • 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality..  74:1252-1259. 2002
  • 17β-estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: Molecular mechanisms and islet functionality.  74:1252-1259. 2002
  • Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells.  74:1159-1166. 2002
  • Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.  74:1090-1095. 2002
  • Simvastatin induces activation of the serine-threonine protein kinase Akt and increases survival of isolated human pancreatic islets.  74:1063-1069. 2002
  • Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury.  74:916-923. 2002
  • The nondirected live-kidney donor: Ethical considerations and practice guidelines. A national conference report.  74:582-589. 2002
  • Analysis of the control of the anti-gal immune response in a non-human primate by galactose α1-3 galactose trisaccharide-polyethylene glycol conjugate.  73:1780-1787. 2002
  • Development and characterization of anti-Gal B cell receptor transgenic Gal-/-mice.  73:1549-1557. 2002
  • Activation of human endothelial cells by mobilized porcine leukocytes in vitro: Implications for mixed chimerism in xenotransplantation.  73:1302-1309. 2002
  • Endothelial function in pigs transgenic for human complement regulating factor.  73:1060-1067. 2002
  • Chlamydia pneumoniae respiratory infection after allogeneic stem cell transplantation.  73:1002-1005. 2002
  • Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to Gal oligosaccharides.  73:129-139. 2002
  • Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade.  73:12-22. 2002
  • Xenotransplantation so close, but yet so far.  73:1-2. 2002
  • Anti-CD154 monoclonal antibody and thromboembolism revisited [2].  74:416-417. 2002
  • CD40-CD154 pathway blockade requires host macrophages to induce humoral unresponsiveness to pig hematopoietic cells in baboons.  72:1759-1768. 2001
  • Pig kidney transplantation in baboons: Anti-galα1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.  72:1743-1752. 2001
  • The structure of anti-Gal immunoglobulin genes in naïve and stimulated Gal knockout mice.  72:1817-1825. 2001
  • Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the phagocytic reticuloendothelial system in baboons.  72:1278-1285. 2001
  • Modulation of platelet aggregation in baboons: Implications for mixed chimerism in xenotransplantation. I. The roles of individual components of a transplantation conditioning regimen and of pig peripheral blood progenitor cells.  72:1299-1305. 2001
  • Modulation of platelet aggregation in baboons: Implications for mixed chimerism in xenotransplantation. II. The effects of cyclophosphamide on pig peripheral blood progenitor cell-induced aggregation.  72:1306-1310. 2001
  • An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells.  72:954-956. 2001
  • Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.  71:1772-1776. 2001
  • The effects of CTLA-4Ig on acute lung allograft rejection: A comparison of intrabronchial gene therapy with systemic administration of protein.  71:1867-1871. 2001
  • Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantation.  71:1601-1609. 2001
  • Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up.  71:1681-1683. 2001
  • Anti-CD154 monoclonal antibody and thromboembolism.  71:491. 2001
  • Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene.  71:1015-1023. 2001
  • The role of anti-Galα1-3Gal antibodies in acute vascular rejection and accommodation of xenografts.  70:1667-1674. 2000
  • Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates.  70:1323-1331. 2000
  • Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70:1323.  70:1273-1274. 2000
  • A differential requirement for CD8+ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells.  70:1068-1073. 2000
  • Long-term results of liver transplantation in patients 60 years of age and older.  70:780-783. 2000
  • Are pigs transgenic for human complement regulatory proteins necessary for xenotransplantation.  70:567-568. 2000
  • Opening of mitochondrial potassium channels: A new target for graft preservation strategies?.  70:576-578. 2000
  • Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: Absence of chronic allograft nephropathy.  69:2497-2503. 2000
  • High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response.  69:2296-2304. 2000
  • Significance of blood stream infection after lung transplantation: Analysis in 176 consecutive patients.  69:2360-2366. 2000
  • Altered intragraft immune responses and imroved renal function in MHC class II-deficient mouse kidney allografts.  69:2137-2143. 2000
  • Gene therapy and transplantation.  69:1995-1999. 2000
  • The safety and efficacy of a two-dose daclizumab (Zenapax) induction therapy in liver transplant recipients.  69:1867-1872. 2000
  • Anti-Galα1-3Gal antibody levels in organ transplant recipients receiving immunosuppressive therapy.  69:914-917. 2000
  • Enhanced allograft survival induced by posttransplant donor spleen cell infusion occurs via a mechanism that is distinct from the mechanism of enhancement by donor bone marrow.  69:1020-1022. 2000
  • Posttransplant lymphoproliferative disorder localized near the allograft in renal transplantation.  69:809-814. 2000
  • Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis.  69:399-405. 2000
  • Long-term functional islet mass and metabolic function after xenoislet transplantation in primates.  69:195-201. 2000
  • Hepatopulmonary syndrome and venous emboli causing intracerebral hemorrhages after liver transplantation: A case report.  68:1809-1811. 1999
  • Peritransplant tolerance induction in macaques: Early events reflecting the unique synergy between immunotoxin and deoxyspergualin.  68:1660-1673. 1999
  • Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: A phase II trial.  68:1526-1532. 1999
  • Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: Results of the U.S. multicenter FK506 kidney transplant study group.  68:1203-1205. 1999
  • Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation.  68:663-671. 1999
  • Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection.  68:310-313. 1999
  • Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients.  68:215-219. 1999
  • Screening by tRNA primer extension analysis of porcine kidney mRNA libraries defines a novel endogenous porcine retroviral long terminal repeat.  67:1391-1395. 1999
  • Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation.  67:1200-1201. 1999
  • Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers.  67:1119-1128. 1999
  • Long-term discordant xenogeneic (porcine-to-primate) bone marrow engraftment in a monkey treated with porcine-specific growth factors.  67:972-977. 1999
  • Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation.  67:775-783. 1999
  • Reversal of naturally occurring diabetes in primates by unmodified islet xenografts without chronic immunosuppression.  67:846-854. 1999
  • Serum cytotoxicity to pig cells and anti-αGal antibody level and specificity in humans and baboons.  67:658-665. 1999
  • Brain death and its influence on donor organ quality and outcome after transplantation.  67:343-348. 1999
  • Immunoregulatory role of CD8alpha in the veto effect..  67:372-380. 1999
  • Immunoregulatory role of CD8α in the veto effect: Transforming growth factor-b1 activation.  67:372-380. 1999
  • Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption.  67:18-30. 1999
  • Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts.  66:1439-1450. 1998
  • Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process?.  66:1300-1306. 1998
  • Distribution of endothelin-1 in transplanted human lungs.  66:806-809. 1998
  • Alterations in mRNA for inducible and endothelial nitric oxide synthase and plasma nitric oxide with rejection and/or infection of allotransplanted lungs.  66:567-572. 1998
  • Discordant organ xenotransplantation in primates: World experience and current status.  66:547-561. 1998
  • A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients.  66:507-515. 1998
  • Anti-Galα1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction.  66:176-182. 1998
  • Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.  66:29-37. 1998
  • Peritransplant tolerance induction with anti-CD3 immunotoxin: A matter of proinflammatory cytokine control.  65:1159-1169. 1998
  • Complement-mediated pulmonary xenograft injury: Studies in swine-to- primate orthotopic single lung transplant models.  65:1084-1093. 1998
  • Long-term outcome of patients transplanted with livers from hepatitis C- positive donors.  65:925-929. 1998
  • Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation (multiple letters).  65:142-145. 1998
  • Intravenous infusion of Galα1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts.  65:346-353. 1998
  • Mycophenolate mofetil for the treatment of a first acute renal allograft rejection.  65:235-241. 1998
  • Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1-3Galβ1-4βGlc-X immunoaffinity column.  65:172-179. 1998
  • Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.  65:180-187. 1998
  • Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy.  64:1255-1261. 1997
  • Treatment with an antioxidant inhibits vascular changes caused by circulating lymphocytes during acute lung rejection in dogs.  64:807-811. 1997
  • Protective effect of reduced glutathione on endothelial function of coronary arteries subjected to prolonged cold storage.  64:660-663. 1997
  • A molecular epidemiological probe for pig microchimerism.  64:347-350. 1997
  • Characteristics of endothelin receptors in acutely rejecting transplanted lungs.  64:209-214. 1997
  • Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: A report of the U.S. multicenter liver study group.  64:258-263. 1997
  • Preclinical studies of allograft tolerance in rhesus monkeys: A novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts.  64:124-135. 1997
  • Effects of pentoxifylline on renal function and blood pressure in cardiac transplant recipients: A randomized trial.  63:1607-1610. 1997
  • Split tolerance induced by immunotoxin in a rhesus kidney allograft model.  63:1339-1345. 1997
  • A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation.  63:977-983. 1997
  • Immunolocalization of acidic fibroblast growth factor and receptors in the tubulointerstitial compartment of chronically rejected human renal allografts.  63:988-995. 1997
  • Anti-GAL IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation.  63:182-186. 1997
  • FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts.  63:1-6. 1997
  • Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.  63:149-155. 1997
  • Endothelin-1 and cell proliferation in lung organ cultures: Implications for lung allografts.  62:1492-1498. 1996
  • In vivo immunoadsorption of antipig antibodies in baboons using a specific Galα1-3Gal column.  62:1379-1384. 1996
  • Glycans derived from porcine stomach mucin are effective inhibitors of natural anti-α-galactosyl antibodies in vitro and after intravenous infusion in baboons.  62:1324-1331. 1996
  • Monoclonal antiidiotypic antibodies neutralize cytotoxic effects of anti-αGal antibodies.  62:837-843. 1996
  • A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection.  62:594-599. 1996
  • Cobra venom factor stimulates anti-α-galactose antibody production in baboons: Implications for pig-to-human xenotransplantation.  62:678-681. 1996
  • Immunolocalization of FGF-1 and receptors in human renal allograft vasculopathy associated with chronic rejection.  62:467-475. 1996
  • Immunolocalization of FGF-1 and receptors in glomerular lesions associated with chronic human renal allograft rejection.  62:190-200. 1996
  • The intragraft CD8+ T cell response in renal allograft rejection in the mouse.  62:96-104. 1996
  • Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model.  61:1222-1228. 1996
  • Characterization of baboon class I major histocompatibility molecules: Implications for baboon-to-human xenotransplantation.  61:989-996. 1996
  • Molecular conjugate-mediated gene transfer into isolated human kidneys.  61:812-817. 1996
  • Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection.  61:722-729. 1996
  • Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3 - A randomized, double-blind placebo-controlled study.  61:573-577. 1996
  • Impact of donor/recipient size matching on outcomes in renal transplantation.  61:383-388. 1996
  • Gas-generating systems in acute renal allograft rejection in the rat: Co-induction of heme oxygenase and nitric oxide synthase.  61:93-98. 1996
  • Protection of xenogeneic cardiac endothelium from human complement by expression of cd59 or daf in transgenic mice.  60:1149-1156. 1995
  • Pretransplant status and patient survival following liver transplantation.  60:920-925. 1995
  • Protective effects of an indenoindole antioxidant on coronary endothelial function after long-term storage.  60:774-778. 1995
  • Newborn baboon serum anti-αgalactosyl antibody levels and cytotoxicity to cultured pig kidney (PK15) cells.  60:520-521. 1995
  • Evaluation of living renal donors: The current practice of US transplant centers.  60:322-327. 1995
  • Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients.  60:225-232. 1995
  • Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy.  60:138-144. 1995
  • Secondary organ allografting after a primary “bridging” xenotransplant.  60:19-22. 1995
  • Auxiliary liver allografting and xenografting in the nonhuman primate.  59:1670-1676. 1995
  • Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.  59:1177-1182. 1995
  • Successful extrarenal transplantation from non - Heart - Beating donors.  59:977-982. 1995
  • Rejection of kidney allografts by MHC class I-deficient mice.  59:746-755. 1995
  • A rapid flow cytometry assay for hla antibody detection using a pooled cell panel covering 14 serological crossreacting groups.  59:626-630. 1995
  • The predictive value of hepatocyte glycogen content on liver allograft biopsy: Correlation with early graft function.  59:141-143. 1995
  • Direct assessment of the antioxidant effects of a new heart preservation solution, celsior: A hemodynamic and electron spin resonance study.  58:739-742. 1994
  • Diagnosis of intestinal transplant rejection using technetium-99m-DTPA.  58:112-113. 1994
  • Endothelin-1 in bronchoalveolar lavage during rejection of allotransplanted lungs.  57:159-161. 1994
  • Evidence that intravenously administered a-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (pk15) and transplanted pig hearts.  58:330-337. 1994
  • Protection of pig kidney (pk15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides.  57:959-963. 1994
  • Renal retransplantation: The role of race, quadruple immunosuppression, and the flow cytometry cross-match.  57:47-54. 1994
  • The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443).  57:640-643. 1994
  • The pig as a potential organ donor for man: A study of potentially transferable disease from donor pig to recipient man.  57:694-703. 1994
  • Alterations in renal interleukin-1 production during kidney transplant rejection in the rat: The effects of high-dose methyprednisolone.  56:1157-1162. 1993
  • Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation.  56:1433-1442. 1993
  • OKT3 rescue for steroid-resistant rejection in adult liver transplantation.  55:87-91. 1993
  • Regulation of cytokine-stimulated vascular cell adhesion molecule-1 expression in renal tubular epithelial cells.  55:172-177. 1993
  • Right ventricular assessment in patients presenting for lung transplantation.  55:1051-1055. 1993
  • Specific intravenous carbohydrate therapy: A new concept in inhibiting antibody-mediated rejection - Experience with ABO-incompatible cardiac allografting in the baboon.  56:769-777. 1993
  • Cytomegalovirus disease in heart transplant patients.  53:1167-1168. 1992
  • Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression.  53:103-109. 1992
  • Proliferation of cytomegalovirus-primed lymphocytes in bronchoalveolar lavages from lung transplant patients.  54:635-639. 1992
  • Rs-61443—a phase i clinical trial and pilot rescue study.  53:428-432. 1992
  • Social rehabilitation and return to work after cardiac transplantation—a multicenter survey.  53:433-438. 1992
  • The chacma baboon as an organ donor for man.  53:1380-1381. 1992
  • The effect of erythropoietin and blood transfusions on highly sensitized patients on a single cadaver renal allograft waiting list.  53:363-368. 1992
  • The impact of the UNOS mandatory sharing policy on recipients of the black and white races-experience at a single renal transplant center.  53:770-774. 1992
  • Hypertonic citrate solution as an alternative to modified euro-collins’ solution for lung preservation.  51:1043-1048. 1991
  • Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.  51:70-75. 1991
  • Problems with therapeutic monitoring of cyclosporine using silicone central venous line samples.  52:1109-1110. 1991
  • RS-61443—A new, potent immunosuppressive agent.  51:27-31. 1991
  • Selective enhancement of β cell activity by preparation of fetal pancreatic proislets and culture with insulin growth factor 1.  51:1161-1165. 1991
  • Survival of ganciclovir-treated heart transplant recipients with cytomegalovirus pneumonitis.  52:910-913. 1991
  • Amelioration of lung ischemic injury with prostacyclin.  49:1031-1035. 1990
  • Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient.  49:311-316. 1990
  • Modulation of ischemic lung injury by corticosteroids.  50:530-532. 1990
  • The use of a prostacyclin analog, iloprost, as an adjunct to pulmonary preservation with euro- collins solution.  49:495-499. 1990
  • Exquisite sensitivity of dendritic cells to ultraviolet radiation and temperature changes.  48:666-671. 1989
  • Functional and morphological studies of long-term islet allografts in the renal subcapsular space of the BB/W rat.  47:580-582. 1989
  • Pituitary function in brain-dead patients.  48:1078-1079. 1989
  • Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera: Race, transplant history, and HLA-DR1 phenotype.  47:240-245. 1989
  • Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.  47:66-71. 1989
  • Xenograft transplantation.  47:408. 1989
  • Xenotransplantation.  47:747. 1989
  • Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy.  45:32-36. 1988
  • Injury of myocardial conduction tissue and coronary artery smooth muscle following brain death in the baboon.  45:964-966. 1988
  • Thyroid function in human cardiac allograft donors.  45:671-672. 1988
  • Donor-specific transfusions in renal transplantation in children effect of azathioprine plus transfusions.  44:159-161. 1987
  • Effect of low-temperature culture and site of transplantation on hamster islet xenograft survival (Hamster to mouse).  44:465-468. 1987
  • Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors.  43:852-854. 1987
  • Loss of myocardial viability following hypothermic perfusion storage from contaminating trace elements in the perfusate.  43:23-28. 1987
  • Primary integumentary allograft reactivity in the American cockroach, periplaneta Americana.  43:514-519. 1987
  • Impairment of renal slice function following brain death, with reversibility of injury by hormonal therapy.  41:29-32. 1986
  • Lethal Graft-Vkrsus-Host disease in a recipient of a pancreas-spleen transplant.  41:544-546. 1986
  • Failure of pretransplant third-party and preoperative donor-specific blood transfusion to improve heterotopic cardiac allograft survival in baboons.  40:569-571. 1985
  • Prolonged survival of donor skin grafts on mice bearing established islet of langerhans transplants.  40:216-218. 1985
  • Immunosuppression in the baboon cardiac allograft model: Effects of splenectomy, bolus methylprednisolone, propranolol, high–dose azathioprine, cyclophosphamide, and a niridazole metabolite.  38:299-300. 1984
  • Primary integumentary xenograft reactivity in the american cockroach, periplaneta Americana.  37:478-484. 1984
  • Reactivity of lymphocyte cytotoxic autoantibodies from renal patients with cell line K562.  38:557-558. 1984
  • Mycobacterial infections in marrow transplant patients.  36:509-513. 1983
  • Possibility of graft-vs-leukemia determinants independent of the major histocompatibility complex in allogeneic marrow transplantation.  35:378-385. 1983
  • Successful renal transplantation despite warm B cell antibodies.  36:207-209. 1983
  • Low-dose versus high-dose steroid therapy in the prevention of acute rejection in baboon heterotopic cardiac allografts.  34:107-108. 1982
  • Qa-1-associated antigens: IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognition.  34:54-59. 1982
  • Twenty-four-hour preservation of the pig heart by a portable hypothermic perfusion system.  34:246-250. 1982
  • An investigation of the immunosuppressive effects of niridazole and metronidazole in rat and baboon heterotopic cardiac allograft models.  31:326. 1981
  • Fatal response suggestive of graft-versus-host reaction following transplantation of spleen cells from allogeneic athymic (Nude) donors.  31:201-204. 1981
  • Improved renal function using adenosine triphosphate-magnesium chloride in preservation of canine kidneys subjected to warm ischemia.  31:187-189. 1981
  • Exponential relationship between spleen cell concentration and fatal graft-versus-host response after transplantation of allogeneic spleen-marrow cell mixtures.  29:507-510. 1980
  • Percutaneous transluminal dilation in renal transplant arterial stenosis.  30:440-444. 1980
  • Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation..  28:443-446. 1979
  • Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation.  27:443-450. 1979
  • Ia and H-2 antigens on blast cells.  19:528-530. 1975
  • A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient..  101:1461-1467.
  • International Standard Serial Number (issn)

  • 0041-1337
  • Electronic International Standard Serial Number (eissn)

  • 1534-6080